Skip to main content

Table 1 Baseline characteristics of the populations

From: Analysis of low-dose estrogen on callus BMD as measured by pQCT in postmenopausal women

Parameters

Placebo (n = 45)

E2 (n = 31)

Age range [years]

55–94

51–89

Age mean [years] ± SD

75.62 ± 10.47; p = 0.1006

71.13 ± 11.99; p = 0.1006

Fractured dominant arm [%]

53.33

29.03

  1. E2 estrogen treated patients; n number of patients; SD standard deviation